Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial

M. K. Han; G. J. Criner; M. T. Dransfield; D. M. G. Halpin; C. E. Jones; S. Kilbride; P. Lange; D. A. Lipson; D. A. Lomas; F. J. Martinez; I. Naya; S. J. Pascoe; R. A. Wise; D. Singh

doi:10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial

M. K. Han, G. J. Criner, M. T. Dransfield, D. M. G. Halpin, C. E. Jones, S. Kilbride, P. Lange, D. A. Lipson, D. A. Lomas, F. J. Martinez, I. Naya, S. J. Pascoe, R. A. Wise, D. Singh

Genome Research and Molecular Bio Medicine

Original language	English
Article number	A102
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	199
Issue number	A2438
ISSN	1073-449X
DOIs	https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438
Publication status	Published - 2019

Access to Document

10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

Cite this

Han, M. K., Criner, G. J., Dransfield, M. T., Halpin, D. M. G., Jones, C. E., Kilbride, S., Lange, P., Lipson, D. A., Lomas, D. A., Martinez, F. J., Naya, I., Pascoe, S. J., Wise, R. A., & Singh, D. (2019). Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial. American Journal of Respiratory and Critical Care Medicine, 199(A2438), Article A102. https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial. / Han, M. K.; Criner, G. J.; Dransfield, M. T. et al.
In: American Journal of Respiratory and Critical Care Medicine, Vol. 199, No. A2438, A102, 2019.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Han, MK, Criner, GJ, Dransfield, MT, Halpin, DMG, Jones, CE, Kilbride, S, Lange, P, Lipson, DA, Lomas, DA, Martinez, FJ, Naya, I, Pascoe, SJ, Wise, RA & Singh, D 2019, 'Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial', American Journal of Respiratory and Critical Care Medicine, vol. 199, no. A2438, A102. https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

Han MK, Criner GJ, Dransfield MT, Halpin DMG, Jones CE, Kilbride S et al. Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial. American Journal of Respiratory and Critical Care Medicine. 2019;199(A2438):A102. doi: 10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

@article{47ffc183ffb24775a93a359268703cf4,

title = "Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial",

author = "Han, {M. K.} and Criner, {G. J.} and Dransfield, {M. T.} and Halpin, {D. M. G.} and Jones, {C. E.} and S. Kilbride and P. Lange and Lipson, {D. A.} and Lomas, {D. A.} and Martinez, {F. J.} and I. Naya and Pascoe, {S. J.} and Wise, {R. A.} and D. Singh",

year = "2019",

doi = "10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438",

language = "English",

volume = "199",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

number = "A2438",

}

TY - ABST

T1 - Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol

T2 - A Prospective Analysis of the IMPACT Trial

AU - Han, M. K.

AU - Criner, G. J.

AU - Dransfield, M. T.

AU - Halpin, D. M. G.

AU - Jones, C. E.

AU - Kilbride, S.

AU - Lange, P.

AU - Lipson, D. A.

AU - Lomas, D. A.

AU - Martinez, F. J.

AU - Naya, I.

AU - Pascoe, S. J.

AU - Wise, R. A.

AU - Singh, D.

PY - 2019

Y1 - 2019

U2 - 10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

DO - 10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

M3 - Conference abstract in journal

SN - 1073-449X

VL - 199

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

IS - A2438

M1 - A102

ER -